The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 3, 2012, Pages 618.e1-618.e13

  Trachtenberg, Aaron J ^a   Filippini, Nicola ^a,b   Cheeseman, Jane ^a,c   Duff, Eugene P ^a   Neville, Matt J ^a   Ebmeier, Klaus P ^b   Karpe, Fredrik ^a,c   Mackay, Clare E ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; APOE; FMRI; Genetics; Imaging

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGE; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANGULAR GYRUS; ANTERIOR HIPPOCAMPUS; ARTICLE; AUDITORY CORTEX; BLOOD OXYGENATION; BLOOD OXYGENATION LEVEL DEPENDENT; BRAIN FUNCTION; BRAIN REGION; ENCODING TASK; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENOTYPE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; INSULA; LINGUAL GYRUS; MALE; NORMAL HUMAN; OCCIPITAL CORTEX; PARAHIPPOCAMPAL GYRUS; PARIETAL CORTEX; PARIETAL OPERCULUM; PLANUM TEMPORALE; POSTCENTRAL GYRUS; POSTERIOR CINGULATE; POSTERIOR HIPPOCAMPUS; PRECUNEUS; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; RISK ASSESSMENT; STROOP TEST; SUPERIOR PARIETAL LOBULE; SUPERIOR TEMPORAL GYRUS; SUPPLEMENTARY MOTOR AREA; SUPRAMARGINAL GYRUS; TASK PERFORMANCE; TEMPORAL FUSIFORM CORTEX;

EID: 84855760452     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.11.011     Document Type: Article

References (65)

1. Beckmann C.F., Jenkinson M., Smith S.M. General multilevel linear modeling for group analysis in FMRI. Neuroimage 2003, 20:1052-1063. 10.1016/S1053-8119(03)00435-X.
2. Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005, 64:501-508.
3. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for alzheimer's disease. N. Engl. J. Med 2000, 343:450-456.
4. Bothwell M., Giniger E. Alzheimer's disease: Neurodevelopment converges with neurodegeneration. Cell 2000, 102:271-273. 10.1016/S0092-8674(00)00032-5.
5. Burggren A.C., Small G.W., Sabb F.W., Bookheimer S.Y. Specificity of brain activation patterns in people at genetic risk for alzheimer disease. Am. J. Geriatr. Psychiatry 2002, 10:44-51.
6. Bush G., Whalen P.J., Rosen B.R., Jenike M.A., McInerney S.C., Rauch S.L. The counting stroop: An interference task specialized for functional neuroimaging-validation study with functional MRI. Hum. Brain Mapp 1998, 6:270-282. 10.1002/(SICI)1097-0193(1998)6:4.
7. Corder E., Saunders A., Risch N., Strittmatter W., Schmechel D., Gaskell P., Rimmler J., Locke P., Conneally P., Schmader K., Small G., Roses A., Haines J., Pericakvance M. Protective effect of apolipoprotein-e type-2 allele for late-onset Alzheimer-disease. Nat. Genet 1994, 7:180-184. 10.1038/ng0694-180.
8. Dennis N., Browndyke J., Stokes J., Need A., Burke J., Welsh-Bohmer K., Cabeza R. Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement. 2010, 6:303-311.
9. Dumanis S.B., Tesoriero J.A., Babus L.W., Nguyen M.T., Trotter J.H., LaDu M.J., Weeber E.J., Turner R.S., Xu B., Rebeck G.W., Hoe H. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J. Neurosci 2009, 29:15317-15322. 10.1523/JNEUROSCI.4026-09.2009.
10. Egner T., Hirsch J. The neural correlates and functional integration of cognitive control in a stroop task. Neuroimage 2005, 24:539-547.
11. Fan J., Flombaum J.I., McCandliss B.D., Thomas K.M., Posner M.I. Cognitive and brain consequences of conflict. Neuroimage 2003, 18:42-57.
12. Farrer L., Cupples L., Haines J., Hyman B., Kukull W., Mayeux R., Myers R., PericakVance M., Risch N., vanDuijn C. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease-A meta-analysis. JAMA 1997, 278:1349-1356.
13. Filbey F.M., Slack K.J., Sunderland T.P., Cohen R.M. Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEε4 in young healthy adults. Neuroreport 2006, 17:1585-1590.
14. Filippini N., MacIntosh B., Hough M., Goodwin G., Frisoni G., Smith S., Matthews P., Beckmann C., Mackay C. Distinct patterns of brain activity in young carriers of the APOE-ε4 allele. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7209-7214.
15. Filippini N., Ebmeier K.P., MacIntosh B.J., Trachteberg A.J., Frisoni G.B., Wilcock G.K., Beckmann C.F., Smith S.M., Matthews P.M., Mackay C.E. Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage 2011, 54:602-610.
16. Fleisher A.S., Houston W.S., Eyler L.T., Frye S., Jenkins C., Thal L.J., Bondi M.W. Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch. Neurol 2005, 62:1881-1888.
17. Fleisher A.S., Podraza K.M., Bangen K.J., Taylor C., Sherzai A., Sidhar K., Liu T.T., Dale A.M., Buxton R.B. Cerebral perfusion and oxygenation differences in alzheimer's disease risk. Neurobiol. Aging 2009, 30:1737-1748.
18. Ghebremedhin E., Schultz C., Botez G., Rüb U., Sassin I., Braak E., Braak H. Argyrophilic grain disease is associated with apolipoprotein E epsilon 2 alleles. Acta Neuropathol. 1998, 96:222-224.
19. Greenberg S.M. Cerebral amyloid angiopathy: Prospects for clinical diagnosis and treatment. Neurology 1998, 51:690-694.
20. Greenberg S.M., Briggs M.E., Hyman B.T., Kokoris G.J., Takis C., Kanter D.S., Kase C.S., Pessin M.S. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996, 27:1333-1337.
21. Greve D.N., Fischl B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 2009, 48:63-72.
22. Han S.D., Bangen K.J., Bondi M.W. Functional magnetic resonance imaging of compensatory neural recruitment in aging and risk for alzheimer's disease: Review and recommendations. Dement. Geriatr. Cogn. Disord 2009, 27:1-10.
23. Han S.D., Houston W.S., Jak A.J., Eyler L.T., Nagel B.J., Fleisher A.S., Brown G.G., Corey-Bloom J., Salmon D.P., Thal L.J., Bondi M.W. Verbal paired-associate learning by APOE genotype in non-demented older adults: FMRI evidence of a right hemispheric compensatory response. Neurobiol. Aging 2007, 28:238-247.
24. Herz J., Beffert U. Apolipoprotein E receptors: Linking brain development and alzheimer's disease. Nat. Rev. Neurosci 2000, 1:51-58.
25. Huang X., Chen P.C., Poole C. APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 2004, 62:2198-2202.
26. Humphries A.D., Streimann I.C., Stojanovski D., Johnston A.J., Yano M., Hoogenraad N.J., Ryan M.T. Dissection of the mitochondrial import and assembly pathway for human Tom40. J. Biol. Chem 2005, 280:11535-11543.
27. Ikeda K., Akiyama H., Arai T., Sahara N., Mori H., Usami M., Sakata M., Mizutani T., Wakabayashi K., Takahashi H. A subset of senile dementia with high incidence of the apolipoprotein E epsilon2 allele. Ann. Neurol 1997, 41:693-695.
28. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal 2001, 5:143-156. 10.1016/S1361-8415(01)00036-6.
29. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
30. Jofre-Monseny L., Minihane A., Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol. Nutr. Food Res 2008, 52:131-145.
31. Kirchhoff B.A., Wagner A.D., Maril A., Stern C.E. Prefrontal-temporal circuitry for episodic encoding and subsequent memory. J. Neurosci 2000, 20:6173-6180.
32. Kukolja J., Thiel C.M., Eggermann T., Zerres K., Fink G.R. Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Neuroscience 2010, 168:487-497.
33. Levi O., Jongen-Relo A.L., Feldon J., Roses A.D., Michaelson D.M. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis 2003, 13:273-282. 10.1016/S0969-9961(03)00045-7.
34. Lind J., Persson J., Ingvar M., Larsson A., Cruts M., Broeckhoven C.V., Adolfsson R., Bäckman L., Nilsson L., Petersson K.M., Nyberg L. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain 2006, 129:1240-1248.
35. Lippa C., Smith T., Saunders A., Hulette C., PulaskiSalo D., Roses A. Apolipoprotein E-epsilon 2 and Alzheimer's disease: Genotype influences pathologic phenotype. Neurology 1997, 48:515-519.
36. Love S., Siew L., Dawbarn D., Wilcock G., Ben-Shlomo Y., Allen S. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol. Aging 2006, 27:797-803.
37. Macleod C.M. Half a century of research on the Stroop effect-an integrative review. Psychol. Bull 1991, 109:163-203. 10.1037/0033-2909.109.2.163.
38. Mahley R., Rall S. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet 2000, 1:507-537.
39. Milham M.P., Banich M.T., Barad V. Competition for priority in processing increases prefrontal cortex's involvement in top-down control: An event-related fMRI study of the stroop task. Cogn. Brain Res 2003, 17:212-222. 10.1016/S0926-6410(03)00108-3.
40. Mitchell R.L.C. The BOLD response during stroop task-like inhibition paradigms: Effects of task difficulty and task-relevant modality. Brain Cogn 2005, 59:23-37.
41. Mondadori C.R., de Quervain D.J., Buchmann A., Mustovic H., Wollmer M.A., Schmidt C.F., Boesiger P., Hock C., Nitsch R.M., Papassotiropoulos A., Henke K. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb. Cortex 2007, 17:1934-1947.
42. Myers R., Schaefer E., Wilson P., Dagostino R., Ordovas J., Espino A., Au R., White R., Knoefel J., Cobb J., Mcnulty K., Beiser A., Wolf P. Apolipoprotein E epsilon 4 association with dementia in a population-based study: The Framingham study. Neurology 1996, 46:673-677.
43. Nagy Z., Esiri M., Jobst K., Johnston C., Litchfield S., Sim E., Smith A. Influence of the apolipoprotein-e genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 1995, 69:757-761. 10.1016/0306-4522(95)00331-C.
44. Nathan B., Bellosta S., Sanan D., Weisgraber K., Mahley R., Pitas R. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994, 264:850-852.
45. Nathan B., Chang K., Bellosta S., Brisch E., Ge N., Mahley R., Pitas R. The inhibitory effect of apolipoprotein e4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem 1995, 270:19791-19799.
46. Nicoll J.A., Burnett C., Love S., Graham D.I., Dewar D., Ironside J.W., Stewart J., Vinters H.V. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann. Neurol 1997, 41:716-721.
47. Perry R.J., Hodges J.R. Attention and executive deficits in Alzheimer's disease. A critical review. Brain 1999, 122:383-404.
48. Perry R.J., Watson P., Hodges J.R. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: Relationship to episodic and semantic memory impairment. Neuropsychologia 2000, 38:252-271. 10.1016/S0028-3932(99)00079-2.
49. Pihlajamäki M., O'Keefe K., Bertram L., Tanzi R., Dickerson B., Blacker D., Albert M., Sperling R. Evidence of altered posteromedial cortical fMRI activity in subjects at risk for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2010, 24:28-36.
50. Premkumar D.R., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol 1996, 148:2083-2095.
51. Reiman E.M., Chen K., Liu X., Bandy D., Yu M., Lee W., Ayutyanont N., Keppler J., Reeder S.A., Langbaum J.B.S., Alexander G.E., Klunk W.E., Mathis C.A., Price J.C., Aizenstein H.J., Dekosky S.T., Caselli R.J. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6820-6825.
52. Rocchi A., Pellegrini S., Siciliano G., Murri L. Causative and susceptibility genes for Alzheimer's disease: A review. Brain Res. Bull 2003, 61:1-24. 10.1016/S0361-9230(03)00067-4.
53. Roses A.D., Lutz M.W., Amrine-Madsen H., Saunders A.M., Crenshaw D.G., Sundseth S.S., Huentelman M.J., Welsh-Bohmer K.A., Reiman E.M. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J. 2009, 10:375-384.
54. Schacter D.L., Wagner A.D. Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus 1999, 9:7-24. 10.1002/(SICI)1098-1063(1999)9:5.
55. Smith C.D., Andersen A.H., Kryscio R.J., Schmitt F.A., Kindy M.S., Blonder L.X., Avison M.J. Women at risk for AD show increased parietal activation during a fluency task. Neurology 2002, 58:1197-1202.
56. Smith J. Apolipoproteins and aging: Emerging mechanisms. Ageing Res. Rev 2002, 1:345-365. 10.1016/S1568-1637(02)00005-3.
57. Trachtenberg A.J., Filippini N., Mackay C.E., et al. The effects of APOE-epsilon4 on the BOLD response. Neurobiol Aging 2010, 10.1016/j.neurobiolaging.2010.03.009.
58. Verpillat P., Camuzat A., Hannequin D., Thomas-Anterion C., Puel M., Belliard S., et al. Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. Eur J Hum Genet 2002, 10:399-405.
59. Wagner A.D., Schacter D.L., Rotte M., Koutstaal W., Maril A., Dale A.M., Rosen B.R., Buckner R.L. Building memories: Remembering and forgetting of verbal experiences as predicted by brain activity. Science 1998, 281:1188-1191.
60. Wishart H.A., Saykin A.J., Rabin L.A., Santulli R.B., Flashman L.A., Guerin S.J., Mamourian A.C., Belloni D.R., Rhodes C.H., McAllister T.W. Increased brain activation during working memory in cognitively intact adults with the APOE ε4 allele. Am. J. Psychiatry 2006, 163:1603-1610.
61. Woodard J.L., Seidenberg M., Nielson K.A., Antuono P., Guidotti L., Durgerian S., Zhang Q., Lancaster M., Hantke N., Butts A., Rao S.M. Semantic memory activation in amnestic mild cognitive impairment. Brain 2009, 132:2068-2078.
62. Woolrich M.W., Ripley B.D., Brady M., Smith S.M. Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 2001, 14:1370-1386.
63. Woolrich M. Robust group analysis using outlier inference. Neuroimage 2008, 41:286-301.
64. Woolrich M.W., Behrens T.E.J., Beckmann C.F., Jenkinson M., Smith S.M. Multilevel linear modelling for FMRI group analysis using bayesian inference. Neuroimage 2004, 21:1732-1747.
65. Wright R.O., Hu H., Silverman E.K., Tsaih S.W., Schwartz J., Bellinger D., Palazuelos E., Weiss S.T., Hernandez-Avila M. Apolipoprotein E genotype predicts 24-month bayley scales infant development score. Pediatr. Res 2003, 54:819-825.